Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
86 Cards in this Set
- Front
- Back
Digoxin MOA
|
Calcium channel blocker
Increases intracellular Ca2+, increasing heart contractility indirectly by inhibiting Na/K pump, which disables Na/Ca pump, keeping calcium in myocardial cells Quinidine, hypercalcemia, hypokalemia-increase digoxin toxicity Digoxin improves contractility of heart, it does not improve survival in CHF |
|
What drug causes a prolonged PR (>200ms) aka 1st degree heart block?
|
Digoxin
|
|
Drugs that improve survival in CHF
|
ACE inhibitors
Spironolactone Metoprolol |
|
What type of drug slows cardiac remodeling and decreases risk of CHF in post-MI patients
|
Captopril (ACE inhibitors)
|
|
Which cardiac enzyme is the most sensitive for MI
|
Troponin
|
|
Nitroglycerin MOA
|
Decreases preload
Nitrates cause the formation of NO, causing venous dilation. Dilated veins store more blood, thus increase preload. Vasodilation will also reduce afterload, reducing cardiac work and oxygen demand |
|
Class IA antiarrhythmics
|
Quinidine
Procainamide Disopyramide |
|
Class IA MOA
|
1. Reduce slope of phase 0 depolarization (slows AP starting) of fast response tissue (atrial & ventricular cells)
2. Increases AP duration |
|
Class IB Drug
|
Lidocaine
|
|
Class IB MOA
|
1. Reduce slope of phase 0 depolarization
(slows AP starting) 2. Decreases AP duration 3. Preferentially affects ischemic tissue |
|
Toxicity of ALL class I antiarrhythmics are increased by
|
HyperK+
|
|
Toxicity of Quinidine (3)
|
Cinchonism (tinnitus, headache)
Torsades de pointes Thrombocytopenia |
|
Antiarrhythmic that increases toxicity of digoxin
|
Quinidine
|
|
Toxicity of Procainamide
|
SLE-like syndrome (anti-histone ABs)
|
|
DOC for POST-MI ventricular arrhythmia
|
Lidocaine
|
|
DOC for Digitalis toxicity
|
Lidocaine
|
|
Toxicity of Lidocaine
|
CNS stimulation (seizures)
|
|
Why do you use class IC antiarrhythmics as a LAST RESORT?
|
Proarrhythmic (especially contraindicated post-MI)
|
|
Class II antiarrhythmics
|
B blockers
|
|
Class II MOA
|
1. Inhibit sympathetics, slowing rate of discharge of abnormal cardiac pacemakers (AV node esp sensitive)
2. Decrease slope of phase 4 |
|
Shortest acting B blocker
|
Esmolol
|
|
Class III antiarrhythmics
|
K+ channel blockers:
Amiodarone Sotalol |
|
Class III antiarrhythmic mostly a K+ channel blocker;
Has class I, II, III and IV effects |
Amiodarone
|
|
Class III antiarrhythmic mostly a K+ channel blocker;
also a B blocker |
Soltalol
|
|
Class III MOA
|
Increases AP duration by prolonging repolarization
|
|
Toxicity of amiodarone (5)
|
Pulmonary fibrosis
Hypo or hyperthyroidism Skin deposits (smurf skin) corneal deposits Hepatotoxicity |
|
Class IV antiarrhythmics
|
Calcium channel blockers:
Verapamil Diltiazem |
|
Toxicity of Class IV
|
Constipation
Edema Flush Cardiac depression |
|
DOC for supraventricular tachycardia; very short 1/2 life (15 sec)
|
Adenosine
|
|
Lipid-Lowering Drugs
|
Lipid-Lowering Drugs
|
|
Statins MOA
|
Inhibit HMG-CoA Reductase
Lower LDL |
|
Toxicity of Statins
|
Rhabdomyolysis
Liver Toxicity |
|
Niacin MOA
|
Inhibits lipolysis in adipose tissue
Reduces VLDL secretion from liver Increases HDL |
|
Toxicity of Niacin
|
Flushed face (reduce w/ aspirin)
Ancanthosis nigricans (hyperglycemia) Hyperuricemia |
|
Bile acid resins (Cholestyramine) MOA
|
Prevent intestinal reab of bile acids
Liver must use more cholesterol to replace bile acids |
|
Toxicity of Bile acid resins
|
Tastes bad
Decreased absorption of fat-soluble vitamins Cholesterol gallstones |
|
Fibrates (gemfibrozil) MOA
|
Upregulate LPL to increase TG clearance
Lowers TG |
|
Toxicity of fibrates
|
Myositis
Hepatoxicity Cholesterol gallstones |
|
Psychiatry Pharm
|
Psychiatry Pharm
|
|
DOC for bulimia
|
SSRIs
|
|
DOC for ADHD
|
Methylphenidate (Ritalin)
Amphetamines |
|
DOC for depression with insomnia
|
Mirtazapine
|
|
DOC for OCD
|
SSRIs
Clomipramine |
|
DOC for PTSD
|
SSRIs
|
|
MOA of Typical antipsychotics
|
Block D2 receptors
|
|
Haloperidol
|
Typical antipsychotic (high-potency)
|
|
Trifluoperazine
|
Typical antipsychotic (high-potency)
|
|
Fluphenazine
|
Typical antipsychotic (high-potency)
|
|
Thioridazine
|
Typical antipsychotic (Low potency)
|
|
Chlorpromazine
|
Typical antipsychotic (Low potency)
|
|
Difference between high-potency vs low-potency Typical antipsychotics
|
High potency=Extrapyramidal symptoms
Low potency=anticholinergic, antihistamine (sedation), alpha blockade (hypotension) |
|
Chlorpromazine SE
|
Corneal deposits
|
|
Thioridazine SE
|
Retinal deposits
|
|
Difference between Typical vs Atypical Antipsychotics
|
Atypical antipsychotics have fewer extrapyramidal and anticholinergic SE.
They also treat BOTH positive and negative symptoms (Typical antipsychotics treat positive symptoms) |
|
Olanzapine
|
Atypical antipsychotic
|
|
Clozapine
|
Atypical antipsychotic
|
|
Quetiapine
|
Atypical antipsychotic
|
|
Risperidone
|
Atypical antipsychotic
|
|
Aripiprazole
|
Atypical antipsychotic
|
|
Ziprasidone
|
Atypical antipsychotic
|
|
2 Atypical antipsychotics that cause significant weight gain
|
Clozapine
Olanzapine |
|
Atypical antipsychotic that causes agranulocytosis (monitor WBCs)
|
Clozapine
|
|
Atypical antipsychotic that prolongs QT interval
|
Ziprasidone
|
|
Amitriptyline, Nortriptyline
|
TCA
|
|
Clomipramine
Imipramine Desipramine |
TCA
|
|
Doxepin
|
TCA
|
|
Amoxapine
|
TCA
|
|
TCA MOA
|
Block reuptake of NE and serotonin
|
|
Which TCA is used for bedwetting
|
Imipramine
|
|
Which TCA is used for OCD
|
Clomipramine
|
|
Which antidepressant class side effects include:
Sedation, alpha-blocking (orthostatic hypotension), atropine-like effects |
TCA
|
|
Toxicity of TCAs and antidote
|
Convulsions
Coma Cardiotoxicity Sodium Bicarbonate |
|
Fluoxetine
|
SSRI
|
|
Paroxetine
|
SSRI
|
|
Setraline
|
SSRI
|
|
Citalopram
|
SSRI
|
|
Which antidepressant class has toxicities that include: sexual dysfunction
|
SSRIs
|
|
Treatment for serotonin syndrome
|
Cyproheptadine (serotonin blocker)
|
|
Tranycypromine
|
MAOI
|
|
Phenelzine
|
MAOI
|
|
Isocarboxazid
|
MAOI
|
|
Selegiline
|
MAO-B Inhibitior
|
|
MAOI increase levels of which NTs?
|
NE, serotonin, dopamine
|
|
Bupropion
|
Atypical antidepressant, increases NE and dopamine; Used for smoking cessation
|
|
Bupropion SE
|
Stimulant effects (tachycardia)
NO sexual side effects |
|
Buspirone
|
Serotonin agonist
Used for generalized anxiety disorder |